Recent News

• 05.12.2026 - Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
• 05.11.2026 - Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
• 05.04.2026 - Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
• 04.24.2026 - Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
• 04.20.2026 - Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

Recent Filings

• 05.12.2026 - 8-K Current report
• 05.12.2026 - EX-99.1 EX-99.1
• 05.12.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.11.2026 - 8-K Current report
• 04.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.28.2026 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.24.2026 - 8-K/A Current report
• 04.23.2026 - 4/A Statement of changes in beneficial ownership of securities
• 04.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.22.2026 - 4 Statement of changes in beneficial ownership of securities